Wilson Mark Andrew

Chief Legal Officer | SVP &General Counsel

1 company

Good

Trades Analyzed

12M Win Rate

50.0%

Avg 3M Return

-3.7%

Avg 12M Return

-3.4%

Wilson Mark Andrew is a Chief Legal Officer at NEKTAR THERAPEUTICS. Recent SEC Form 4 filings include 0 buys and 10 sells.

Estimated insider holdings value: $1.8M based on current market prices.

Holdings by Company

NKTRNov 25, 2025

Current Shares21.6K

Value$1.77M

Net Activity-169,627

Bought: 0Sold: 169.6K

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 16, 2023	NKTR Nektar Therapeutics	Chief Legal Officer	Sell	7,221	$0.78	$5,632.38	-2.8%	-33.6%	+54.9%
May 16, 2023	NKTR Nektar Therapeutics	Chief Legal Officer	Sell	7,543	$0.72	$5,430.96	-2.8%	+15.2%	+155.9%
Feb 16, 2023	NKTR Nektar Therapeutics	Chief Legal Officer	Sell	8,275	$3.00	$24,825.00	-3.0%	-76.5%	-76.1%
Nov 16, 2022	NKTR Nektar Therapeutics	Chief Legal Officer	Sell	8,690	$3.57	$31,023.30	-3.1%	-14.2%	-85.7%
Aug 16, 2022	NKTR Nektar Therapeutics	SVP &General Counsel	Sell	3,189	$4.76	$15,179.64	-1.1%	-12.8%	-83.6%
May 16, 2022	NKTR Nektar Therapeutics	SVP &General Counsel	Sell	3,136	$3.95	$12,387.20	-2.6%	+26.5%	-81.6%
Feb 16, 2022	NKTR Nektar Therapeutics	SVP &General Counsel	Sell	3,661	$10.95	$40,087.95	-2.9%	-64.8%	-73.4%
Nov 16, 2021	NKTR Nektar Therapeutics	SVP &General Counsel	Sell	6,564	$13.16	$86,382.24	-7.1%	-18.3%	-73.5%
Aug 16, 2021	NKTR Nektar Therapeutics	SVP &General Counsel	Sell	1,910	$13.83	$26,415.30	-2.6%	-3.1%	-66.0%
May 17, 2021	NKTR Nektar Therapeutics	SVP &General Counsel	Sell	1,917	$18.30	$35,081.10	-2.5%	-24.3%	-78.3%